A specific drug targeting system based on polyhydroxyalkanoate granule binding protein PhaP fused with targeted cell ligands
- 31 December 2008
- journal article
- Published by Elsevier in Biomaterials
- Vol. 29 (36), 4823-4830
- https://doi.org/10.1016/j.biomaterials.2008.09.008
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Emerging vectors and targeting methods for nonviral gene therapyEmerging Drugs, 2006
- Polyhydroxyalkanoate (PHA)/Inorganic Phase Composites for Tissue Engineering ApplicationsBiomacromolecules, 2006
- The application of polyhydroxyalkanoates as tissue engineering materialsBiomaterials, 2005
- Polymers for DNA DeliveryMolecules, 2005
- Designing materials for biology and medicineNature, 2004
- Bone generation on PHBV matrices: an in vitro studyBiomaterials, 2003
- Polyhydroxyalkanoate (PHA) scaffolds with good mechanical properties and biocompatibilityBiomaterials, 2002
- Synthetic DNA delivery systemsNature Biotechnology, 2000
- Biodegradable block copolymers as injectable drug-delivery systemsNature, 1997
- On the biodegradation of poly-β-hydroxybutyrate (PHB) homopolymer and poly-β-hydroxybutyrate-hydroxyvalerate copolymersBiomaterials, 1987